comparemela.com

Latest Breaking News On - Redchip financial communications united states - Page 1 : comparemela.com

Aptorum Group Limited: Aptorum Group Announces Completion of End of Phase 1 (EOP1) Meeting with US FDA on its SACT-1, a Repurposed Small Molecule Drug Targeting Neuroblastoma

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical-stage biopharmaceutical company, announces the completion of an end of Phase 1

Dennis riedlClark chengCraig brelsfordGhislaine gasparettoAptorum group formAptorum group orDrug administrationSingapore agency for scienceActifin financial communications europeRedchip financial communications united statesDaptorum groupAptorum group limited nasdaqRegulatory newsGroup limitedEuronext parisChief medical officer

Aptorum Group Limited: Aptorum Group Announces Completion of Pre-IND Discussions with US FDA on its ALS-4, a First-in-Class Small Molecule Drug Targeting Methicillin Resistant Staphylococcus Aureus

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical-stage biopharmaceutical company, announces the completion of the Pre-IND discussions

United statesDennis riedlClark chengCraig brelsfordGhislaine gasparettoAptorum group formAptorum group orDrug administrationSingapore agency for scienceActifin financial communications europeRedchip financial communications united statesDaptorum groupAptorum group limited nasdaqRegulatory newsGroup limitedEuronext paris

Aptorum Group Limited: Aptorum Group Launches NativusWell, a Novel Nutraceutical for Menopause, in China

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group"), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics to tackling

United statesUnited kingdomDennis riedlCraig brelsfordGhislaine gasparettoAptorum group formInvestor relations departmentSingapore agency for scienceActifin financial communications europeRedchip financial communications united statesDaptorum groupAptorum group limited nasdaqRegulatory newsGroup limitedEuronext parisMol struct

Aptorum Group Limited: Aptorum Group Regains Compliance with Nasdaq Minimum Bid Price and Receives Nasdaq Notification of Minimum Market Value of Publicly Held Shares Deficiency

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology

Craig brelsfordGhislaine gasparettoAptorum group formAptorum group orHearing panelInvestor relations departmentSingapore agency for scienceActifin financial communications europeRedchip financial communications united statesCompany classa ordinaryDaptorum groupAptorum group limited nasdaqNasdaq stock marketNasdaq listing qualifications departmentRegulatory newsGroup limited

Aptorum Group Limited: Aptorum Group Announces 1-for-10 Reverse Stock Split

Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (the "Company") a clinical stage biopharmaceutical company dedicated to tackling unmet medical needs in oncology, autoimmune

Craig brelsfordGhislaine gasparettoAptorum group formCompany board of directorsInvestor relations departmentCompany classb ordinarySingapore agency for scienceActifin financial communications europeRedchip financial communications united statesDaptorum groupCompany classa ordinaryAptorum group limited nasdaqRegulatory newsGroup limitedEuronext parisOrdinary shares

vimarsana © 2020. All Rights Reserved.